Development of a live attenuated vaccine candidate against duck Tembusu viral disease

Virology

Volumn 450-451, Issue , 2014, Pages 233-242

  Li, Guoxin ^a   Gao, Xuyuan ^a   Xiao, Yali ^a   Liu, Shaoqiong ^a   Peng, Shan ^a   Li, Xuesong ^a   Shi, Ying ^a   Zhang, Yuee ^a   Yu, Lei ^a   Wu, Xiaogang ^a   Yan, Pixi ^a   Yan, Liping ^a   Teng, Qiaoyang ^a   Tong, Guangzhi ^a   Li, Zejun ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Attenuation; Duck Tembusu virus; Flavivirus

Indexed keywords

LIVE VACCINE; VIRUS RNA; VIRUS VACCINE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BIRD DISEASE; CONTROLLED STUDY; DUCK TEMBUSU VIRAL DISEASE; EGG; EMBRYO; FEMALE; FIBROBLAST; GENE DOSAGE; IMMUNITY; IMMUNOGENICITY; INFECTION RESISTANCE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ATTENUATION; DUCK TEMBUSU VIRUS; FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; DUCKS; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; MICE; MICE, INBRED BALB C; POULTRY DISEASES; VACCINES, ATTENUATED; VIRAL VACCINES; VIRULENCE;

EID: 84891783081     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.12.028     Document Type: Article

References (49)

1. Barrett A.D., Teuwen D.E. Yellow fever vaccine-how does it work and why do rare cases of serious adverse events take place?. Curr. Opin. Immunol. 2009, 21:308-313.
2. Beasley D.W., Whiteman M.C., Zhang S., Huang C.Y., Schneider B.S., Smith D.R., Gromowski G.D., Higgs S., Kinney R.M., Barrett A.D. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 2005, 79:8339-8347.
3. Butrapet S., Huang C.Y., Pierro D.J., Bhamarapravati N., Gubler D.J., Kinney R.M. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J. Virol. 2000, 74:3011-3019.
4. Chiou S.S., Chen W.J. Mutations in the NS3 gene and 3'-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus. Virology 2001, 289:129-136.
5. Ciota A.T., Lovelace A.O., Ngo K.A., Le A.N., Maffei J.G., Franke M.A., Payne A.F., Jones S.A., Kauffman E.B., Kramer L.D. Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture. Virology 2007, 357:165-174.
6. Engel A.R., Rumyantsev A.A., Maximova O.A., Speicher J.M., Heiss B., Murphy B.R., Pletnev A.G. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome. Virology 2010, 405:243-252.
7. Goto A., Hayasaka D., Yoshii K., Mizutani T., Kariwa H., Takashima I. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness. Vaccine 2003, 21:4043-4051.
8. Halstead S.B., Thomas S.J. Japanese encephalitis: new options for active immunization. Clin. Infect. Dis. 2010, 50:1155-1164.
9. Hase T., Dubois D.R., Summers P.L., Downs M.B., Ussery M.A. Comparison of replication rates and pathogenicities between the SA14 parent and SA14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Arch. Virol. 1993, 130:131-143.
10. Hennessy S., Liu Z., Tsai T.F., Strom B.L., Wan C.M., Liu H.L., Wu T.X., Yu H.J., Liu Q.M., Karabatsos N., Bilker W.B., Halstead S.B. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 1996, 347:1583-1586.
11. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., Kotchasenee S., Gingrich J.B., Latendresse J., Fukai K., et al. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 1988, 319:608-614.
12. Holzmann H., Heinz F.X., Mandl C.W., Guirakhoo F., Kunz C. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 1990, 64:5156-5159.
13. Holzmann H., Stiasny K., Ecker M., Kunz C., Heinz F.X. Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J. Gen. Virol. 1997, 78:31-37.
14. Huang X., Han K., Zhao D., Liu Y., Zhang J., Niu H., Zhang K., Zhu J., Wu D., Gao L., Li Y. Identification and molecular characterization of a novel flavivirus isolated from geese in China. Res. Vet. Sci. 2012, 94:774-780.
15. Jiang W.R., Lowe A., Higgs S., Reid H., Gould E.A. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol. 1993, 74(Pt 5):931-935.
16. Kumar R., Tripathi P., Rizvi A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N. Engl. J. Med. 2009, 360:1465-1466.
17. Li S., Li X., Zhang L., Wang Y., Yu X., Tian K., Su W., Han B., Su J. Duck Tembusu virus exhibits neurovirulence in BALB/c mice. Virol. J. 2013, 10:260.
18. Li X., Li G., Teng Q., Yu L., Wu X., Li Z. Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus. PLoS One 2013, 7:e53026.
19. Liu M., Chen S., Chen Y., Liu C., Yin X., Li G., Zhang Y. Adapted Tembusu-like virus in chickens and geese in China. J. Clin. Microbiol. 2012, 50:2807-2809.
20. Liu Z., Ji Y., Huang X., Fu Y., Wei J., Cai X., Zhu Q. An adapted duck Tembusu virus induces systemic infection and mediates antibody-dependent disease severity in mice. Virus Res. 2013, 176:216-222.
21. Liu Z.L., Hennessy S., Strom B.L., Tsai T.F., Wan C.M., Tang S.C., Xiang C.F., Bilker W.B., Pan X.P., Yao Y.J., Xu Z.W., Halstead S.B. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J. Infect. Dis. 1997, 176:1366-1369.
22. Maier C.C., Delagrave S., Zhang Z.X., Brown N., Monath T.P., Pugachev K.V., Guirakhoo F. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus. Virology 2007, 362:468-474.
23. Mandl C.W., Allison S.L., Holzmann H., Meixner T., Heinz F.X. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J. Virol. 2000, 74:9601-9609.
24. Markoff L., Pang X., Houng Hs, H.S., Falgout B., Olsen R., Jones E., Polo S. Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys. J. Virol. 2002, 76:3318-3328.
25. McArthur M.A., Holbrook M.R. Japanese encephalitis vaccines. J. Bioterror. Biodef. 2013, S1:2.
26. Mitzel D.N., Best S.M., Masnick M.F., Porcella S.F., Wolfinbarger J.B., Bloom M.E. Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity. Virology 2008, 381:268-276.
27. Monath T.P. Yellow fever. Vaccines 1999, 815-880. Saunders, Philadelphia. 3rd ed. S. Plotkin, W.A. Orenstein (Eds.).
28. Monath T.P. Prospects for development of a vaccine against the West Nile virus. Ann. N. Y. Acad. Sci. 2001, 951:1-12.
29. Monath T.P., McCarthy K., Bedford P., Johnson C.T., Nichols R., Yoksan S., Marchesani R., Knauber M., Wells K.H., Arroyo J., Guirakhoo F. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 2002, 20:1004-1018.
30. Puig-Basagoiti F., Tilgner M., Bennett C.J., Zhou Y., Munoz-Jordan J.L., Garcia-Sastre A., Bernard K.A., Shi P.Y. A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. Virology 2007, 361:229-241.
31. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
32. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995, 375:291-298.
33. Ruzek D., Gritsun T.S., Forrester N.L., Gould E.A., Kopecky J., Golovchenko M., Rudenko N., Grubhoffer L. Mutations in the NS2B and NS3 genes affect mouse neuroinvasiveness of a Western European field strain of tick-borne encephalitis virus. Virology 2008, 374:249-255.
34. Solomon T. Control of Japanese encephalitis-ithin our grasp?. N. Engl. J. Med. 2006, 355:869-871.
35. Tang Y., Diao Y., Yu C., Gao X., Ju X., Xue C., Liu X., Ge P., Qu J., Zhang D. Characterization of a Tembusu virus isolated from naturally infected house sparrows (Passer domesticus) in Northern China. Transbound. Emerg. Dis. 2012, 60:152-158.
36. Tang Y., Gao X., Diao Y., Feng Q., Chen H., Liu X., Ge P., Yu C. Tembusu virus in human, China. Transbound. Emerg. Dis. 2013, 60:193-196.
37. Wicker J.A., Whiteman M.C., Beasley D.W., Davis C.T., McGee C.E., Lee J.C., Higgs S., Kinney R.M., Huang C.Y., Barrett A.D. Mutational analysis of the West Nile virus NS4B protein. Virology 2012, 426:22-33.
38. Wicker J.A., Whiteman M.C., Beasley D.W., Davis C.T., Zhang S., Schneider B.S., Higgs S., Kinney R.M., Barrett A.D. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology 2006, 349:245-253.
39. Yamshchikov G., Borisevich V., Seregin A., Chaporgina E., Mishina M., Mishin V., Kwok C.W., Yamshchikov V. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development. Virology 2004, 330:304-312.
40. Yan L., Peng S., Yan P., Zhou J., Teng Q., Li G., Li X., Li Z. Comparison of real-time reverse transcription loop-mediated isothermal amplification and real-time reverse transcription polymerase chain reaction for duck Tembusu virus. J. Virol. Methods 2012, 182:50-55.
41. Yan L., Yan P., Zhou J., Teng Q., Li Z. Establishing a TaqMan-based real-time PCR assay for the rapid detection and quantification of the newly emerged duck Tembusu virus. Virol. J. 2011, 8:464.
42. Yan P., Zhao Y., Zhang X., Xu D., Dai X., Teng Q., Yan L., Zhou J., Ji X., Zhang S., Liu G., Zhou Y., Kawaoka Y., Tong G., Li Z. An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology 2011, 417:1-8.
43. Yoshii K., Igarashi M., Ito K., Kariwa H., Holbrook M.R., Takashima I. Construction of an infectious cDNA clone for Omsk hemorrhagic fever virus, and characterization of mutations in NS2A and NS5. Virus Res. 2010, 155:61-68.
44. Yu L., Markoff L. The topology of bulges in the long stem of the flavivirus 3' stem-loop is a major determinant of RNA replication competence. J. Virol. 2005, 79:2309-2324.
45. Yu L., Robert Putnak J., Pletnev A.G., Markoff L. Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations. Vaccine 2008, 26:5981-5988.
46. Yu Y. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 2010, 28:3635-3641.
47. Zhang S., Li L., Woodson S.E., Huang C.Y., Kinney R.M., Barrett A.D., Beasley D.W. A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology 2006, 353:35-40.
48. Zhang W., Chipman P.R., Corver J., Johnson P.R., Zhang Y., Mukhopadhyay S., Baker T.S., Strauss J.H., Rossmann M.G., Kuhn R.J. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 2003, 10:907-912.
49. Zhao Z., Date T., Li Y., Kato T., Miyamoto M., Yasui K., Wakita T. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J. Gen. Virol. 2005, 86:2209-2220.